Healthcare Innovation

As the deadly Bundibugyo Ebola strain spreads with no approved vaccine, a small pharma company is positioning its cancer drug as a potential broad-spectrum shield.

A new study reveals treating advanced gum disease has up to 10x the environmental impact of prevention, reframing sustainability from recycling to daily habits.

Teva's new Eylea biosimilar hits Europe, a key move in its 'Pivot to Growth' strategy that promises to shake up the lucrative ophthalmology market.

A key regulatory win in Japan propels a potential first-ever treatment for Netherton Syndrome, but the real story is the high-wire act of global commercialization.

Beyond greenwashing, the animal health giant's latest report reveals a calculated strategy where innovation, philanthropy, and climate action drive market leadership.

As burnout rates hit crisis levels, Mynoo Maryel's bestselling 'FLOW' offers a radical alternative. Is it possible to achieve more by sacrificing less?

A first-in-class drug aims to calm overactive immune cells, offering a new blueprint for treating diseases like rheumatoid arthritis. But can it deliver?

The world's largest veterinary conference, VMX 2027, confronts industry burnout with its 'Off the Grid' theme, blending professional renewal with science.

The renewed pact between PENTAX Medical and FUJIFILM promises over a decade of support for their EUS systems, a strategic move in a booming med-tech market.

A crucial CAP accreditation for its advanced CNS cancer test positions Plus Therapeutics to unlock new markets and redefine patient care with precision diagnostics.

A Florida biotech is using a novel gene therapy to correct aging-related errors. But the real story is its funding: a decentralized, crypto-style model.

Hivemind Capital and UC Berkeley launch darkmatter lab, a novel model to inject capital and resources into frontier research before it becomes a company.

A new podcast, The Golden Ball, teams a World Cup star with Jungian experts to explore how soccer's drama offers a powerful playbook for personal growth.

A strategic shift in research funding is backing novel science that targets glial cells, not just neurons. This could be a critical turning point in the fight against ALS.

Newsweek's 2026 list is more than a guide for parents; it's a window into the future of pediatric care. We break down the complex metrics.

A new partnership uses healthcare data expertise to guide military caregivers through a mental health crisis. But is this innovative solution enough?

The men's supplement industry is shifting from pure performance to holistic vitality. A new launch reveals the economic and scientific forces driving this change.

With a potential $4 billion on the line, CytomX and Regeneron are building a new class of cancer therapies designed to act like autonomous agents in the body.

Nirrin Technologies launches TALOS™, a system using novel laser spectroscopy to eliminate dilution and variability, promising a new standard for biomanufacturing.

A recent FDA approval for a generic cancer drug adds to a growing market, revealing the strategic alliances redefining healthcare access.